CompletedPHASE1, PHASE2NCT01441076

Anakinra for Behcet s Disease

Studying Marfan syndrome type 1

Last synced from ClinicalTrials.gov May 4, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Principal Investigator: Peter C Grayson, M.D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Intervention: Anakinra(drug)
Enrollment: 6 enrolled
Eligibility: 18-65 years · All sexes
Timeline: 2011 – 2014

Study locations (1)

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01441076 on ClinicalTrials.gov

Other trials for Marfan syndrome type 1

Additional recruiting or active studies for the same condition.

RECRUITINGNCT07037732
Circulating B-cell, Drug and Anti-drug Antibodies Monitoring in Patients Treated With Rituximab for Autoimmune Disorders
Centre Hospitalier Universitaire de Nice

See all trials for Marfan syndrome type 1 →

← Back to all trials